Ghost Tree Capital »

Arcus Biosciences Incorporated shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.3M 75k 17.95
2023-06-30 $1.5M 75k 20.31
2023-03-31 $1.4M 75k 18.24

More positions owned by Ghost Tree Capital

Spdr Ser Tr S&p Biotech Put Option (XBI)
Biohaven Call
Sarepta Therapeutics (SRPT)
Novo-nordisk A S Adr (NVO)
Blueprint Medicines (BPMC)
Axsome Therapeutics (AXSM)
Tarsus Pharmaceuticals (TARS)
Perspective Therapeutics Com New (CATX)
Cg Oncology (CGON)
Roivant Sciences SHS (ROIV)
Vaxcyte (PCVX)
Insmed Com Par $.01 (INSM)
Viking Therapeutics (VKTX)
Syndax Pharmaceuticals (SNDX)
Janux Therapeutics (JANX)

View all positions for Ghost Tree Capital

Top funds holding Arcus Biosciences Incorporated

Gilead Sciences
BlackRock
Vanguard Group
Point72 Asset Management
Woodline Partners
Suvretta Capital Management
State Street Corporation
Siren
FMR
Balyasny Asset Management
Geode Capital Management
Dimensional Fund Advisors
Barclays
Bnp Paribas Investment Partners
Wellington Management Company

View all funds holding Arcus Biosciences Incorporated